Chikungunya vaccine, live (cvx 317) Disease Interactions
There is 1 disease interaction with chikungunya vaccine, live (cvx 317).
Vaccines (live attenuated/toxoid) (applies to chikungunya vaccine, live (cvx 317)) immunocompromised
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency
The expected antibody responses may not be obtained when live attenuated vaccines and/or toxoids are administered to immunosuppressed persons, including those receiving immunosuppressive therapy. Caution and close monitoring is advised.
References (9)
- (2005) "Product Information. Menactra (meningococcal conjugate vaccine)." sanofi pasteur
- (2022) "Product Information. ActHIB (Hib) (haemophilus b conjugate (PRP-T) vaccine)." sanofi pasteur
- (2022) "Product Information. Bexsero (meningococcal group B vaccine)." Novartis Vaccines & Diagnostics Inc
- (2022) "Product Information. Trumenba (meningococcal group B vaccine)." Pfizer U.S. Pharmaceuticals Group
- (2022) "Product Information. Hiberix (Hib) (haemophilus b conjugate (PRP-T) vaccine)." GlaxoSmithKline
- (2016) "Product Information. Vaxchora (cholera vaccine, live)." PaxVax
- (2022) "Product Information. Vaxchora (cholera vaccine, live)." Emergent Travel Health, Inc
- (2023) "Product Information. Ixchiq (cvx 317) (chikungunya vaccine, live (cvx 317))." Valneva USA
- (2025) "Product Information. Penmenvy (cvx 328) (meningococcal group ACWY conjugate-group B vaccine (cvx 328))." GlaxoSmithKline
Switch to consumer interaction data
Chikungunya vaccine, live (cvx 317) drug interactions
There are 339 drug interactions with chikungunya vaccine, live (cvx 317).
Report options
More about chikungunya vaccine, live (cvx 317)
- chikungunya vaccine, live (cvx 317) consumer information
- Check interactions
- Compare alternatives
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: viral vaccines
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Ixchiq
Ixchiq is a chikungunya virus vaccine used to prevent chikungunya disease, it is a live, weakened ...
Abrysvo
Abrysvo is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
ACAM2000
ACAM2000 vaccine may be used to prevent smallpox and mpox disease in people of any age at high risk ...
Afluria
Afluria is a vaccine used to prevent infection caused by influenza virus. Learn about side effects ...
Afluria Preservative-Free Pediatric Quadrivalent
Afluria Preservative-Free Pediatric Quadrivalent is used for influenza prophylaxis
Afluria Preservative-Free Quadrivalent
Afluria Preservative-Free Quadrivalent is used for influenza prophylaxis
Afluria Quadrivalent
Afluria Quadrivalent is used for influenza prophylaxis
Arexvy
Arexvy is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
